Upside Surprises More Likely Than Downside for Alexion Pharmaceuticals, Says Credit Suisse

By: via Benzinga
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares have plummeted 35 percent year-to-date. Credit Suisse’s Alethia Young ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.